These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 16387162

  • 41. Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients.
    Press RR, Ploeger BA, den Hartigh J, van der Straaten T, van Pelt J, Danhof M, de Fijter JW, Guchelaar HJ.
    Ther Drug Monit; 2009 Apr; 31(2):187-97. PubMed ID: 19258929
    [Abstract] [Full Text] [Related]

  • 42. The influence of calcineurin inhibitors on mycophenolic acid pharmacokinetics.
    Kuriata-Kordek M, Boratynska M, Falkiewicz K, Porazko T, Urbaniak J, Wozniak M, Patrzalek D, Szyber P, Klinger M.
    Transplant Proc; 2003 Sep; 35(6):2369-71. PubMed ID: 14529944
    [Abstract] [Full Text] [Related]

  • 43. Assessment of cyclosporine pharmacokinetic parameters to facilitate conversion from C0 to C2 monitoring in heart transplant recipients.
    Davies RA, Veinot JP, Williams K, Haddad H, Baker A, Donaldson J, Pugliese C, Struthers C, Masters RG, Hendry PJ, Mesana T.
    Transplant Proc; 2007 Dec; 39(10):3334-9. PubMed ID: 18089382
    [Abstract] [Full Text] [Related]

  • 44. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
    Alloway R, Steinberg S, Khalil K, Gourishankar S, Miller J, Norman D, Hariharan S, Pirsch J, Matas A, Zaltzman J, Wisemandle K, Fitzsimmons W, First MR.
    Transplant Proc; 2005 Mar; 37(2):867-70. PubMed ID: 15848559
    [Abstract] [Full Text] [Related]

  • 45. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B, Taieb F, Conti F, Abbas H, Seydi I, Harcouet L, Dauphin A, Calmus Y, Tod M.
    Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
    [Abstract] [Full Text] [Related]

  • 46. The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients.
    Akbas SH, Bilgen T, Keser I, Tuncer M, Yucetin L, Tosun O, Gultekin M, Luleci G.
    Transplant Proc; 2006 Jun; 38(5):1290-2. PubMed ID: 16797284
    [Abstract] [Full Text] [Related]

  • 47. Decision support tool to individualize cyclosporine dose in stable, long-term heart transplant recipients receiving metabolic inhibitors: overcoming limitations of cyclosporine C2 monitoring.
    Ray JE, Keogh AM, McLachlan AJ.
    J Heart Lung Transplant; 2006 Oct; 25(10):1223-9. PubMed ID: 17045935
    [Abstract] [Full Text] [Related]

  • 48. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.
    Barten MJ, Streit F, Boeger M, Dhein S, Tarnok A, Shipkova M, Armstrong VW, Mohr FW, Oellerich M, Gummert JF.
    Transplantation; 2004 Apr 27; 77(8):1154-62. PubMed ID: 15114077
    [Abstract] [Full Text] [Related]

  • 49. Reliability of mycophenolic acid monitoring by an enzyme multiplied immunoassay technique.
    Martiny D, Macours P, Cotton F, Thiry P, Gulbis B.
    Clin Lab; 2010 Apr 27; 56(7-8):345-53. PubMed ID: 20857899
    [Abstract] [Full Text] [Related]

  • 50. Dose-adjusted and dose/kg-adjusted concentrations of mycophenolic acid precursors reflect metabolic ratios of their metabolites in contrast with tacrolimus and cyclosporine.
    Hryniewiecka E, Żegarska J, Żochowska D, Samborowska E, Jaźwiec R, Kosieradzki M, Nazarewski S, Dadlez M, Pączek L.
    Biosci Rep; 2019 Sep 30; 39(9):. PubMed ID: 31395739
    [Abstract] [Full Text] [Related]

  • 51. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
    Naito T, Mino Y, Otsuka A, Ushiyama T, Ito T, Ozono S, Kagawa Y, Kawakami J.
    J Clin Pharmacol; 2009 Jun 30; 49(6):710-8. PubMed ID: 19451405
    [Abstract] [Full Text] [Related]

  • 52. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE, El-Dahshan K, Mahmoud K, Ismail AM, El-Baz M, Shokeir AA, Ghoneim MA.
    Exp Clin Transplant; 2008 Sep 30; 6(3):203-10. PubMed ID: 18954298
    [Abstract] [Full Text] [Related]

  • 53. Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood.
    Barten MJ, Dhein S, Chang H, Bittner HB, Tarnok A, Rahmel A, Mohr FW, Gummert JF.
    J Immunol Methods; 2003 Dec 30; 283(1-2):99-114. PubMed ID: 14659903
    [Abstract] [Full Text] [Related]

  • 54. Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction.
    Shitrit D, Ollech JE, Ollech A, Bakal I, Saute M, Sahar G, Kramer MR.
    J Heart Lung Transplant; 2005 Dec 30; 24(12):2148-52. PubMed ID: 16364864
    [Abstract] [Full Text] [Related]

  • 55. New concepts in cyclosporine pharmacokinetic and dynamic monitoring: the impact of concomitant immunosuppression on target C2 concentrations.
    Brunet M, Millán O, Jiménez O, Campistol JM, Vidal E, Rojo I, Oppenheimer F, Fortuna V, Martorell J.
    Transplant Proc; 2004 Mar 30; 36(2 Suppl):437S-441S. PubMed ID: 15041382
    [Abstract] [Full Text] [Related]

  • 56. Postural hand tremor before and following liver transplantation and immunosuppression with cyclosporine or tacrolimus in patients without clinical signs of hepatic encephalopathy.
    Paul F, Müller J, Christe W, Steinmüller T, Poewe W, Wissel J.
    Clin Transplant; 2004 Aug 30; 18(4):429-33. PubMed ID: 15233821
    [Abstract] [Full Text] [Related]

  • 57. Pharmacokinetics of mycophenolic acid associated with calcineurin inhibitors: long-term monitoring in stable lung recipients with and without cystic fibrosis.
    Gerbase MW, Fathi M, Spiliopoulos A, Rochat T, Nicod LP.
    J Heart Lung Transplant; 2003 May 30; 22(5):587-90. PubMed ID: 12742423
    [Abstract] [Full Text] [Related]

  • 58. Mycophenolic acid monitoring in HTX patients: a preliminary report.
    Müller MM, Vogl M, Griesmacher A.
    Therapie; 1997 May 30; 52(4):341-4. PubMed ID: 9437889
    [Abstract] [Full Text] [Related]

  • 59. Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics.
    Gummert JF, Barten MJ, Sherwood SW, van Gelder T, Morris RE.
    J Pharmacol Exp Ther; 1999 Dec 30; 291(3):1100-12. PubMed ID: 10565830
    [Abstract] [Full Text] [Related]

  • 60. Steady-state pharmacokinetics of mycophenolic acid in renal transplant patients: exploratory analysis of the effects of cyclosporine, recipients' and donors' ABCC2 gene variants, and their interactions.
    Božina N, Lalić Z, Nađ-Škegro S, Borić-Bilušić A, Božina T, Kaštelan Ž, Trkulja V.
    Eur J Clin Pharmacol; 2017 Sep 30; 73(9):1129-1140. PubMed ID: 28624888
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.